Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Previous close
$126.50
Day range
$118.50 - $124.00
Year range
$54.10 - $277.00
Market cap
188.02B TWD
Avg Volume
7.00M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 12.41M | 32.54% |
Operating expense | 129.69M | -4.18% |
Net income | 80.19M | 242.84% |
Net profit margin | 646.17 | 207.77% |
Earnings per share | 0.05 | 266.67% |
EBITDA | -114.79M | 6.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.86B | -49.73% |
Total assets | 9.47B | -3.03% |
Total liabilities | 63.66M | -13.62% |
Total equity | 9.41B | — |
Shares outstanding | 1.55B | — |
Price to book | 20.87 | — |
Return on assets | -3.19% | — |
Return on capital | -3.21% | — |
Cash Flow
Net change in cash
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 80.19M | 242.84% |
Cash from operations | -61.00M | -45.21% |
Cash from investing | -2.10B | -0.02% |
Cash from financing | -132.76M | -832.49% |
Net change in cash | -2.22B | -4.33% |
Free cash flow | -90.97M | -40.39% |
About
Founded
2012
Website
